000 | 01991 a2200541 4500 | ||
---|---|---|---|
005 | 20250515043301.0 | ||
264 | 0 | _c20070118 | |
008 | 200701s 0 0 eng d | ||
022 | _a1434-6621 | ||
024 | 7 |
_a10.1515/CCLM.2006.229 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMourad, Michel | |
245 | 0 | 0 |
_aThe influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function. _h[electronic resource] |
260 |
_bClinical chemistry and laboratory medicine _c2006 |
||
300 |
_a1192-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBody Weight |
650 | 0 | 4 | _aCytochrome P-450 CYP3A |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
650 | 0 | 4 |
_aKidney _xphysiology |
650 | 0 | 4 | _aKidney Function Tests |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrganic Anion Transporters _xgenetics |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
700 | 1 | _aWallemacq, Pierre | |
700 | 1 | _aDe Meyer, Martine | |
700 | 1 | _aBrandt, Dimitri | |
700 | 1 | _aVan Kerkhove, Valérie | |
700 | 1 | _aMalaise, Jacques | |
700 | 1 | _aChaïb Eddour, Djamila | |
700 | 1 | _aLison, Dominique | |
700 | 1 | _aHaufroid, Vincent | |
773 | 0 |
_tClinical chemistry and laboratory medicine _gvol. 44 _gno. 10 _gp. 1192-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1515/CCLM.2006.229 _zAvailable from publisher's website |
999 |
_c16608654 _d16608654 |